Interleukin (IL)-17/IL-22-producing T Cells Enriched Within the Liver of Patients with Chronic Hepatitis C Viral (HCV) Infection

Overview

Journal Dig Dis Sci

Specialty Gastroenterology

Date 2011 Dec 21

PMID 22183819

Citations 43

Authors

Richard G Foster

Lucy Golden-Mason

Alleluiah Rutebemberwa

Hugo R Rosen

Affiliations

Soon will be listed here.

Abstract

Background: Effector CD4+ helper T cells have historically been classified into T helper 1 (Th1) and Th2 based on the production of signature cytokines. The recently identified interleukin (IL)-17 cytokine family plays important roles in host immunity against intracellular pathogens and in chronic inflammatory conditions; data have implicated IL-17 in autoimmune and viral liver disease.

Methods: This study used three patient groups with HCV infection: acute HCV who either cleared spontaneously or became chronically infected (n = 12), endstage liver disease from whom both peripheral and intrahepatic lymphocytes were studied directly ex vivo (n = 11), and 134 patients with different stages of HCV-related fibrosis from whom serum was collected concurrently with liver biopsy. Normal healthy subjects (n = 41) served as controls.

Results: Acute HCV was not associated with expansion of either CD4+ or CD8+ T cells producing IL-17 (Th17, Tc17) or IL-22, and frequencies did not differ in the blood of patients who cleared versus became persistently infected. The hepatic compartment of chronic HCV patients demonstrated statistically more CD4+ and CD8+ that produced IL-17, IL-22 or both as compared to peripheral blood. These T cells displayed a distinct phenotypic profile, high expression of the homing receptor CD161 and low levels of inhibitory receptors, mucin-domain-containing-molecule-3 (Tim-3) and programmed-death 1. Using a sensitive ELISA, we found no significant differences in serum levels of IL-17 according to HCV-related fibrosis.

Conclusions: In chronic HCV, T cells producing IL-17/IL-22 may home to the liver; however, circulating levels of IL-17 do not correlate with fibrosis.

Citing Articles

Biomarkers in Detection of Hepatitis C Virus Infection.

Woo J, Choi Y Pathogens. 2024; 13(4).

PMID: 38668286 PMC: 11054098. DOI: 10.3390/pathogens13040331.

Friend or Foe - Tc17 cell generation and current evidence for their importance in human disease.

Hipp A, Bengsch B, Globig A Discov Immunol. 2024; 2(1):kyad010.

PMID: 38567057 PMC: 10917240. DOI: 10.1093/discim/kyad010.

Unraveling IL-17 and IL-22 role in occult hepatitis C versus chronic hepatitis C virus infection.

Elbaz S, Mousa N, Elmetwalli A, Abdel-Razik A, Salah M, Elhammady A BMC Infect Dis. 2024; 24(1):134.

PMID: 38273234 PMC: 10811848. DOI: 10.1186/s12879-024-09032-6.

Human in vitro-induced IL-17A+ CD8+ T-cells exert pro-inflammatory effects on synovial fibroblasts.

Gray E, Srenathan U, Durham L, Lalnunhlimi S, Steel K, Catrina A Clin Exp Immunol. 2023; 214(1):103-119.

PMID: 37367825 PMC: 10711358. DOI: 10.1093/cei/uxad068.

Current Knowledge of Th22 Cell and IL-22 Functions in Infectious Diseases.

Zhang K, Chen L, Zhu C, Zhang M, Liang C Pathogens. 2023; 12(2).

PMID: 36839448 PMC: 9965464. DOI: 10.3390/pathogens12020176.

References

Wang C, Krantz E, Klarquist J, Krows M, McBride L, Scott E . Acute hepatitis C in a contemporary US cohort: modes of acquisition and factors influencing viral clearance. J Infect Dis. 2007; 196(10):1474-82. DOI: 10.1086/522608. View

Davis G, Albright J, Cook S, Rosenberg D . Projecting future complications of chronic hepatitis C in the United States. Liver Transpl. 2003; 9(4):331-8. DOI: 10.1053/jlts.2003.50073. View

Wolk K, Kunz S, Witte E, Friedrich M, Asadullah K, Sabat R . IL-22 increases the innate immunity of tissues. Immunity. 2004; 21(2):241-54. DOI: 10.1016/j.immuni.2004.07.007. View

Kolls J, Khader S . The role of Th17 cytokines in primary mucosal immunity. Cytokine Growth Factor Rev. 2010; 21(6):443-8. PMC: 3004678. DOI: 10.1016/j.cytogfr.2010.11.002. View

Lemmers A, Moreno C, Gustot T, Marechal R, Degre D, Demetter P . The interleukin-17 pathway is involved in human alcoholic liver disease. Hepatology. 2009; 49(2):646-57. DOI: 10.1002/hep.22680. View

Radziewicz H, Ibegbu C, Hon H, Osborn M, Obideen K, Wehbi M . Impaired hepatitis C virus (HCV)-specific effector CD8+ T cells undergo massive apoptosis in the peripheral blood during acute HCV infection and in the liver during the chronic phase of infection. J Virol. 2008; 82(20):9808-22. PMC: 2566282. DOI: 10.1128/JVI.01075-08. View

Harada K, Shimoda S, Sato Y, Isse K, Ikeda H, Nakanuma Y . Periductal interleukin-17 production in association with biliary innate immunity contributes to the pathogenesis of cholangiopathy in primary biliary cirrhosis. Clin Exp Immunol. 2009; 157(2):261-70. PMC: 2730852. DOI: 10.1111/j.1365-2249.2009.03947.x. View

Zhang J, Zhang Z, Lin F, Zou Z, Xu R, Jin L . Interleukin-17-producing CD4(+) T cells increase with severity of liver damage in patients with chronic hepatitis B. Hepatology. 2009; 51(1):81-91. DOI: 10.1002/hep.23273. View

Zhang X, Angkasekwinai P, Dong C, Tang H . Structure and function of interleukin-17 family cytokines. Protein Cell. 2011; 2(1):26-40. PMC: 4875287. DOI: 10.1007/s13238-011-1006-5. View

10.

McMahan R, Golden-Mason L, Nishimura M, McMahon B, Kemper M, Allen T . Tim-3 expression on PD-1+ HCV-specific human CTLs is associated with viral persistence, and its blockade restores hepatocyte-directed in vitro cytotoxicity. J Clin Invest. 2010; 120(12):4546-57. PMC: 2994339. DOI: 10.1172/JCI43127. View

11.

Rowan A, Fletcher J, Ryan E, Moran B, Hegarty J, OFarrelly C . Hepatitis C virus-specific Th17 cells are suppressed by virus-induced TGF-beta. J Immunol. 2008; 181(7):4485-94. DOI: 10.4049/jimmunol.181.7.4485. View

12.

Theise N . Liver biopsy assessment in chronic viral hepatitis: a personal, practical approach. Mod Pathol. 2007; 20 Suppl 1:S3-14. DOI: 10.1038/modpathol.3800693. View

13.

Billerbeck E, Kang Y, Walker L, Lockstone H, Grafmueller S, Fleming V . Analysis of CD161 expression on human CD8+ T cells defines a distinct functional subset with tissue-homing properties. Proc Natl Acad Sci U S A. 2010; 107(7):3006-11. PMC: 2840308. DOI: 10.1073/pnas.0914839107. View

14.

Cosmi L, De Palma R, Santarlasci V, Maggi L, Capone M, Frosali F . Human interleukin 17-producing cells originate from a CD161+CD4+ T cell precursor. J Exp Med. 2008; 205(8):1903-16. PMC: 2525581. DOI: 10.1084/jem.20080397. View

15.

Zhao L, Tang Y, You Z, Wang Q, Liang S, Han X . Interleukin-17 contributes to the pathogenesis of autoimmune hepatitis through inducing hepatic interleukin-6 expression. PLoS One. 2011; 6(4):e18909. PMC: 3079758. DOI: 10.1371/journal.pone.0018909. View

16.

Chang Q, Wang Y, Zhao Q, Wang C, Hu Y, Wu B . Th17 cells are increased with severity of liver inflammation in patients with chronic hepatitis C. J Gastroenterol Hepatol. 2011; 27(2):273-8. DOI: 10.1111/j.1440-1746.2011.06782.x. View

17.

Khader S, Gopal R . IL-17 in protective immunity to intracellular pathogens. Virulence. 2010; 1(5):423-7. PMC: 2953849. DOI: 10.4161/viru.1.5.12862. View

18.

Wu W, Li J, Chen F, Zhu H, Peng G, Chen Z . Circulating Th17 cells frequency is associated with the disease progression in HBV infected patients. J Gastroenterol Hepatol. 2010; 25(4):750-7. DOI: 10.1111/j.1440-1746.2009.06154.x. View

19.

Rosen H . Clinical practice. Chronic hepatitis C infection. N Engl J Med. 2011; 364(25):2429-38. DOI: 10.1056/NEJMcp1006613. View